Cresco Labs Obtains DEA Registration for Medical Cannabis Facility
CHICAGO — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio …
Read the full articleYou might also wanna read
Medical Cannabis Patient Data Breach Exposes Sensitive Health Records in Ohio
Nearly a million records, which appear to be linked to a medical-cannabis-card company in Ohio, included Social Security numbers, government
StockTalk | Cannabis Report: New tech on display
Cannabix Technologies Inc. (CSE:BLO) and Omega Laboratories, Inc. announced the development and validation of a DOT-like drug-test panel for

Cannabis medicinal: setor cresceu 35% em um ano e atrai cerca de 1 milhão de brasileiros
Devem-se contar nos dedos os setores industriais que crescem mais do que aqueles ligados à cannabis medicinal, que encerrou o 1º quadrimestr
US Justice Department reclassifies cannabis from Schedule I to Schedule III drug
Medical marijuana was moved into a lower category of drugs in order to increase research and access.

Redefining DEA compliance for reverse logistics with Axway CSOS
“Each return of a controlled substance is more than a transaction – it’s a test of compliance, efficiency, and integrity.” The moment for ch

Future-enable controlled substance ordering to achieve compliance and speed
The DEA is launching its new Controlled Substance Ordering System (CSOS) on December 9, 2024, to facilitate electronic ordering of controlle

Comments
Sign in to join the conversation.
No comments yet. Be the first.